Merck expects 2022 sales up nearly 20 percent, mostly on molnupiravir Ruchika Sharma6 Feb 2022 9:00 AM ISTNew Delhi: Merck & Co said on Thursday it expects its 2022 sales to increase as much as 18 percent over last year, mostly on sales of its new...
Merck COVID drug Molnupiravir last choice for US patients: Report Ruchika Sharma2 Feb 2022 12:07 PM ISTNew Delhi: Merck & Co's new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four...
Fate of Pfizer COVID pill Paxlovid to be decided by EU regulator by January end: Report Ruchika Sharma26 Jan 2022 9:30 AM ISTBrussels: The European Union's drug regulator is set to decide whether to approve Pfizer's Covid-19 pill at the end of this month, before a final...
No USFDA approval for Merck cough drug Gefapixant Ruchika Sharma25 Jan 2022 12:47 PM ISTNew Delhi: Merck & Co said on Monday the U.S. Food and Drug Administration declined to approve its experimental drug for the treatment...
Merck COVID pill Molnupiravir likely to get WHO recommendation in February Ruchika Sharma15 Jan 2022 1:00 PM ISTNew Delhi: The World Health Organization (WHO) is currently reviewing Merck's COVID-19 antiviral oral pill molnupiravir and a recommendation will...
Merck, Eisai get Japanese nod for cancer cocktail drug Keytruda, Lenvima Ruchika Sharma30 Dec 2021 12:22 PM ISTKenilworth: Merck, known as MSD outside the United States and Canada, and Eisai have announced that the Japanese Ministry of Health, Labour and...
Merck, Ridgeback Molnupiravir gets special approval for emergency in Japan Ruchika Sharma25 Dec 2021 2:46 PM ISTKenilworth: Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan's Ministry of Health,...
Health Bulletin 24/December/2021 Roshni Dhar24 Dec 2021 6:00 PM ISTHere are Top Health stories of the dayDoctors Indemnity Not For Hospital: Supreme CourtThe Supreme Court has recently observed that if a hospital is...
Finally Molnupiravir gets USFDA nod Ruchika Sharma24 Dec 2021 11:36 AM ISTKenilworth: A day after Pfizer's Paxlovid bagged the U.S. Food and Drug Administration (USFDA) Emergency Use Authorization (EUA) nod, Merck's...
USFDA to authorize Pfizer, Merck COVID pills this week: Report Ruchika Sharma22 Dec 2021 10:00 AM ISTNew Delhi: The U.S. Food and Drug Administration is set to authorize COVID-19 treatment pills from both Pfizer Inc and Merck as early as December...
Merck gets positive EU CHMP opinion for Keytruda as adjuvant therapy in RCC following surgery Medical Dialogues Bureau19 Dec 2021 10:00 AM ISTKenilworth: Merck known as MSD outside the United States and Canada, has announced the Committee for Medicinal Products for Human Use (CHMP) of the...
Merck gets USFDA approval for adjuvant Keytruda for pediatric, adult Melanoma Ruchika Sharma5 Dec 2021 9:30 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (USFDA) has approved...
